| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.54 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |